Design, Synthesis and Biological Evaluation of N 6‐Substituted‐ C 2‐Alkynyl‐4′‐Thionucleoside and 4′‐Trucatedthionucleoside Derivatives as Novel A 3 Adenosine Receptor Ligands
ChemMedChem · 2025
DOI: 10.1002/cmdc.202500135 ↗Kurz gefasst
Fachartikel in der Zeitschrift ChemMedChem, 2025. Verfasst von Vikas R Aswar und 4 weiteren Autor:innen. Beteiligte Einrichtung: Research Institute of Pharmaceutical Sciences, College of Pharmacy, Seoul National University, Seoul, 08826, Republic of Korea. Hauptthemen laut MEDLINE: Receptor, Adenosine A3, Drug Design, Thionucleosides, Adenosine A3 Receptor Agonists. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 43 Literaturangaben. Gefördert von: National Research Foundation of Korea, Korea Health Industry Development Institute.
Abstract (Originalsprache)
Adenosine receptors (ARs) play crucial roles in various physiological processes, making them significant targets for therapeutic intervention. This study focuses on the design, synthesis, and evaluation of N 6‐substituted‐ C 2‐alkynyl‐4′‐thioadenosine and truncated 4′‐thioadenosine derivatives as selective ligands for the human A 3 adenosine receptor (hA 3 AR). Binding affinity assays demonstrated that modifications at the C 2‐alkyne and N 6‐amine positions significantly influenced receptor selectivity and potency. Compound 3b showed high affinity for hA 3 AR ( K i = 1.8 nM) with excellent subtype selectivity and acted as an agonist. In contrast, truncated derivative 6b was an antagonist, while 6s , which shares the same sugar structure as 6b , functioned as a partial agonist, highlighting the roles of sugar and base moieties in ligand function. Molecular docking studies provided further insight into distinct binding modes, demonstrating the impact of minor structural variations on ligand‐receptor binding dynamics. These findings contribute to the development of potent and selective A 3 AR modulators by emphasizing the importance of fine structural adjustments in ligand design.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Research Institute of Pharmaceutical Sciences, College of Pharmacy, Seoul National University, Seoul, 08826, Republic of Korea.
- College of Pharmacy and Graduate School of Pharmaceutical Sciences, Ewha Womans University, Seoul, 03760, Republic of Korea.
ORCID-Profile: Jinha Yu, Lak Shin Jeong
Förderung
- National Research Foundation of Korea
- Korea Health Industry Development Institute
Zitieren
APA
Aswar, V. R., Jarhad, D. B., Song, J., Yu, J., & Jeong, L. S. (2025). Design, Synthesis and Biological Evaluation of N 6‐Substituted‐ C 2‐Alkynyl‐4′‐Thionucleoside and 4′‐Trucatedthionucleoside Derivatives as Novel A 3 Adenosine Receptor Ligands. ChemMedChem. https://doi.org/10.1002/cmdc.202500135
Vancouver
Aswar VR, Jarhad DB, Song J, Yu J, Jeong LS. Design, Synthesis and Biological Evaluation of N 6‐Substituted‐ C 2‐Alkynyl‐4′‐Thionucleoside and 4′‐Trucatedthionucleoside Derivatives as Novel A 3 Adenosine Receptor Ligands. ChemMedChem. 2025. doi:10.1002/cmdc.202500135
BibTeX
@article{Aswar2025,
author = {Aswar, Vikas R and Jarhad, Dnyandev B and Song, Jiyoon and Yu, Jinha and Jeong, Lak Shin},
title = {Design, Synthesis and Biological Evaluation of N 6‐Substituted‐ C 2‐Alkynyl‐4′‐Thionucleoside and 4′‐Trucatedthionucleoside Derivatives as Novel A 3 Adenosine Receptor Ligands},
journal = {ChemMedChem},
year = {2025},
doi = {10.1002/cmdc.202500135}
}
EUVIMED